Dyer M A, Hayes P J, Baron M H
Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
Mol Cell Biol. 1998 May;18(5):2617-28. doi: 10.1128/MCB.18.5.2617.
The human embryonic beta-like globin (epsilon-globin) gene is expressed in primitive erythroid cells of the yolk sac during the first few weeks of development. We have previously shown that developmental stage-specific expression of the epsilon-globin gene is mediated by multiple positive and negative regulatory elements upstream of the start of transcription. Of particular interest is one positive regulatory element, PRE II, that works together with other elements (PRE I and PRE V) to confer developmental stage- and/or tissue-specific expression on a minimal promoter. An approximately 85- to 90-kDa PRE II binding factor (PREIIBF) was identified in the nuclei of erythroid cells and shown to bind specifically to a novel 19-bp region within PRE II; binding of this protein to PRE II resulted in bending of the target DNA and was required for promoter activation. In this report, we present the cDNA expression cloning of PREIIBF. The cDNA encodes a previously identified member of the HMG domain family of DNA binding proteins termed SSRP1. By a number of biochemical and immunological criteria, recombinant SSRP1 appears to be identical to the PREII binding factor from erythroid nuclei. A hallmark of HMG domain proteins is their ability to bend their target DNAs; therefore, as we speculated previously, DNA bending by SSRP1/PREIIBF may contribute to the mechanism by which PRE II synergizes with other regulatory elements located upstream and downstream. In contrast with reports from other investigators, we demonstrate that SSRP1 binds DNA with clear sequence specificity. Moreover, we show that SSRP1/PREIIBF lacks a classical activation domain but that binding by this protein to PRE II is required for activation of a minimal promoter in stable erythroid cell lines. These studies provide the first evidence that SSRP1 plays a role in transcriptional regulation. SSRP1/PREIIBF may serve an architectural function by helping to coordinate the assembly of a multiprotein complex required for stage-specific regulation of the human epsilon-globin gene.
人类胚胎β样珠蛋白(ε-珠蛋白)基因在发育的最初几周内在卵黄囊的原始红细胞中表达。我们先前已经表明,ε-珠蛋白基因的发育阶段特异性表达是由转录起始上游的多个正负调控元件介导的。特别令人感兴趣的是一个正调控元件PRE II,它与其他元件(PRE I和PRE V)共同作用,赋予最小启动子发育阶段和/或组织特异性表达。在红细胞核中鉴定出一种约85至90 kDa的PRE II结合因子(PREIIBF),并证明它能特异性结合PRE II内一个新的19 bp区域;该蛋白与PRE II的结合导致靶DNA弯曲,这是启动子激活所必需的。在本报告中,我们展示了PREIIBF的cDNA表达克隆。该cDNA编码一种先前鉴定的DNA结合蛋白HMG结构域家族成员,称为SSRP1。根据一些生化和免疫学标准,重组SSRP1似乎与来自红细胞核的PRE II结合因子相同。HMG结构域蛋白的一个标志是它们能够使靶DNA弯曲;因此,正如我们先前推测的那样,SSRP1/PREIIBF引起的DNA弯曲可能有助于PRE II与位于上游和下游的其他调控元件协同作用的机制。与其他研究者的报告相反,我们证明SSRP1以明确的序列特异性结合DNA。此外,我们表明SSRP1/PREIIBF缺乏经典的激活结构域,但该蛋白与PRE II的结合是稳定红细胞系中最小启动子激活所必需的。这些研究提供了第一个证据,表明SSRP1在转录调控中起作用。SSRP1/PREIIBF可能通过帮助协调人类ε-珠蛋白基因阶段特异性调控所需的多蛋白复合物的组装来发挥结构功能。